Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM
Sign Up to like & getrecommendations! Published in 2022 at "Advances in Therapy"
DOI: 10.1007/s12325-022-02138-w
Abstract: We aimed to compare the efficacy of insulin degludec/insulin aspart (IDegAsp) and insulin degludec/liraglutide (IDegLira) in controlling glucose fluctuation and suppressing postprandial glucose levels using intermittently scanned continuous glucose monitoring. Twenty-four patients with type 2… read more here.
Keywords: idegasp; time range; study; ideglira ... See more keywords
IDegLira Improves Glycemic Control in Japanese Patients with Uncontrolled Type 2 Diabetes on Premixed Insulin Therapy
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes Therapy"
DOI: 10.1007/s13300-019-00730-y
Abstract: Introduction DUAL II Japan (NCT02911948) was a 26-week, phase 3a randomized, treat-to-target trial which compared the efficacy and safety of IDegLira with degludec in 210 Japanese patients with type 2 diabetes (T2D) uncontrolled on premixed or basal insulin… read more here.
Keywords: insulin; trial; insulin therapy; premixed insulin ... See more keywords
Modalités d’instauration d’un traitement par association fixe Degludec-Liraglutide en situation de vie réelle : étude multicentrique française
Sign Up to like & getrecommendations! Published in 2018 at "Annales d'Endocrinologie"
DOI: 10.1016/j.ando.2018.06.206
Abstract: Objectif Analyser les modalites d’instauration de l’association fixe Degludec-Liraglutide (IdegLira), chez des sujets diabetiques de type 2 (DT2) en situation de « vie reelle ». Patients et methodes Cette etude multicentrique a analyse retrospectivement les conditions de… read more here.
Keywords: insuline basale; situation vie; fixe degludec; degludec liraglutide ... See more keywords
1110-P: Use of IDegLira Is Associated with High Persistency Rates Up to 12 Months (M) and Improved A1C after 6M in Swedish Clinical Practice
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes"
DOI: 10.2337/db19-1110-p
Abstract: This retrospective study examines outcomes associated with use of IDegLira - a fixed-ratio insulin degludec/liraglutide combination - in a large real-world cohort of patients with type 2 diabetes in Sweden. Data were obtained from the… read more here.
Keywords: ideglira; improved a1c; use ideglira; persistency ... See more keywords
Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial
Sign Up to like & getrecommendations! Published in 2018 at "Diabetes Care"
DOI: 10.2337/dc17-1114
Abstract: OBJECTIVE In patients with uncontrolled type 2 diabetes on basal insulin, prandial insulin may be initiated. We assessed the efficacy and safety of initiating insulin degludec/liraglutide fixed-ratio combination (IDegLira) versus basal-bolus insulin. RESEARCH DESIGN AND… read more here.
Keywords: insulin; basal; basal bolus; type diabetes ... See more keywords